ÂÜÀòÂÒÂ×

Max Bernstein has a diverse work experience spanning various roles and companies. Their most recent position is as the Senior Medical Director at ClinicalMind, starting in January 2023. Prior to this, they worked as a Medical Director at the same company from April 2022 to January 2023. Max also has experience at 21GRAMS, where they held the positions of Director, Medical Strategy from October 2021 to April 2022, and Associate Director, Medical Strategy from November 2020 to October 2021. Max previously worked as a Medical Director and Associate Medical Director at ClinicalMind from January 2020 to November 2020 and from July 2018 to January 2020, respectively. Before that, Max was a Senior Medical Writer and Medical Writer at BGB Group from January 2018 to July 2018 and from December 2016 to January 2018, respectively. Max's earlier experiences include working as an Instructor at New York University in 2015 and as a Graduate Teaching Assistant at the same institution from September 2010 to December 2012. Max also served as a Research Technician at Albert Einstein College of Medicine from September 2007 to July 2010, where they managed a lab and conducted supervised research.

Max Bernstein obtained their Bachelor's Degree in Biology/Biological Sciences, General from Cornell University, where they studied from 2002 to 2006. Max then pursued a Doctor of Philosophy (Ph.D.) in Genomics at New York University, completing their studies from 2010 to 2016.